Clorox wipes receive EPA registration for <i>C. diff</i>
BALTIMORE — The Clorox Company has announced that the U.S. Environmental Protection Agency (EPA) accepted the registration of Clorox Commercial Solutions'' Germicidal Wipes to kill Clostridium difficile (C. diff) spores in five minutes, according to a press release.
The bleach wipe used by the most U.S. hospitals, Clorox Germicidal Wipes are ready-to-use, hospital-grade disinfectant wipes and are among the strongest and heaviest on the market today, the release stated.
According to the release, Clorox Germicidal Wipes contain an amount of sodium hypochlorite, which exceeds the U.S. Centers for Disease Control and Prevention (CDC) recommended requirement, to kill many of the pathogens of most concern to hospitals.
"The EPA registration reinforces Clorox''s commitment to reducing the spread of infections and disease-causing pathogens, such as C. diff, while providing useful and important tools to the health care community," said Craig Stevenson, vice president and general manager of Clorox Professional Products Company.
"Clorox Germicidal Wipes provide a fast, highly effective way to help keep the patient environment disinfected and is an excellent addition to Clorox''s comprehensive products to kill C. diff spores," Stevenson added.
Clorox Germicidal Wipes are suitable for use on most hard, nonporous surfaces, including stainless steel, and are offered in multiple packaging options that can be adapted for use in various health care locations, the release noted.
Click here to read the complete release.